NeuroPace (NPCE) Change in Cash (2020 - 2026)
NeuroPace's (NPCE) quarterly Change in Cash came in at -$6.2 million in Q1 2026, down 145.5% year-on-year from $13.6 million in Q1 2025, and down 692.24% quarter-over-quarter from $1.0 million in Q4 2025.
NeuroPace (NPCE) Change in Cash (2020 - 2026) Analysis & Trends
NeuroPace's Change in Cash history runs 7 years deep, the most recent figure standing at -$6.2 million for Q1 2026.
- On a quarterly basis, Change in Cash fell 145.5% year-over-year to -$6.2 million in Q1 2026; TTM through Mar 2026 was -$11.5 million, a 182.09% decrease from a year earlier, with the FY2025 full-year figure at $8.3 million, up 278.52% from the prior year.
- Change in Cash retreated to -$6.2 million in Q1 2026 per NPCE's latest filing, from $1.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $13.6 million in Q1 2025 and bottomed at -$11.7 million in Q1 2022.
- The 5-year median for Change in Cash is -$14000.0 (2022), against an average of -$216352.9.
- Across the five-year window, Change in Cash soared 13400.0% in 2023 and sank 4500.0% in 2024, its largest moves.
- Year by year, Change in Cash stood at $917000.0 in 2022, then surged by 809.6% to $8.3 million in 2023, then tumbled by 123.83% to -$2.0 million in 2024, then jumped by 152.52% to $1.0 million in 2025, then slumped by 692.24% to -$6.2 million in 2026.
- Per Business Quant, the three latest NPCE Change in Cash figures stand at -$6.2 million (Q1 2026), $1.0 million (Q4 2025), and -$2.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | -6.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.18 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | -2.21 Mn |
| Jun 30, 2025 | -4.16 Mn |
| Mar 31, 2025 | 13.59 Mn |
| Dec 31, 2024 | -1.99 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | -154,000.00 |
| Mar 31, 2024 | -5.06 Mn |
| Dec 31, 2023 | 8.34 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 115,000.00 |
| Dec 31, 2022 | 917,000.00 |
| Sep 30, 2022 | -14,000.00 |
| Jun 30, 2022 | -1.79 Mn |
| Mar 31, 2022 | -11.70 Mn |
| Dec 31, 2021 | -7.45 Mn |
| Sep 30, 2021 | -4.61 Mn |
| Jun 30, 2021 | 17.16 Mn |